BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23085872)

  • 1. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
    Soars MG; Webborn PJ; Riley RJ
    Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.
    Cressman AM; Petrovic V; Piquette-Miller M
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):69-89. PubMed ID: 22142160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane transporters in drug development.
    Keogh JP
    Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.
    Ramboer E; Vanhaecke T; Rogiers V; Vinken M
    Drug Metab Rev; 2013 May; 45(2):196-217. PubMed ID: 23368091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transporter assays as useful in vitro tools in drug discovery and development.
    Volpe DA
    Expert Opin Drug Discov; 2016; 11(1):91-103. PubMed ID: 26512742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
    Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position.
    Kalvass JC; Polli JW; Bourdet DL; Feng B; Huang SM; Liu X; Smith QR; Zhang LK; Zamek-Gliszczynski MJ;
    Clin Pharmacol Ther; 2013 Jul; 94(1):80-94. PubMed ID: 23588303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intestinal absorption and renal excretion mediated by transporters and the relationship with drug-drug interaction].
    Zhang J; Liu KX
    Yao Xue Xue Bao; 2010 Sep; 45(9):1089-94. PubMed ID: 21351563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter biology in drug approval: regulatory aspects.
    Maeda K; Sugiyama Y
    Mol Aspects Med; 2013; 34(2-3):711-8. PubMed ID: 23506904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
    Kusuhara H; Sugiyama Y
    Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporter-mediated drug delivery: recent progress and experimental approaches.
    Sai Y; Tsuji A
    Drug Discov Today; 2004 Aug; 9(16):712-20. PubMed ID: 15341785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery.
    Kramer W
    Biol Chem; 2011 Jan; 392(1-2):77-94. PubMed ID: 21194371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of membrane transporters in drug delivery to brain tumors.
    Nies AT
    Cancer Lett; 2007 Aug; 254(1):11-29. PubMed ID: 17275180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the dominant role of transporters in drug uptake by cells.
    Dobson PD; Lanthaler K; Oliver SG; Kell DB
    Curr Top Med Chem; 2009; 9(2):163-81. PubMed ID: 19200003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transporter-mediated drug-drug interactions.
    Zhang L; Huang SM; Lesko LJ
    Clin Pharmacol Ther; 2011 Apr; 89(4):481-4. PubMed ID: 21423238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.